For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor with much lower safety risks compared with a direct oral anticoagulant (DOAC), ...
The research could further complicate the polarized politics of abortion because the drug in the study is the key ingredient in a pill used for emergency contraception.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback